Atlas Trials

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

Clinical trial NCT00810602 · COMPLETED

Trial details

NCT number
NCT00810602
Sponsor
Pavan Reddy, MD
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic MalignanciesGraft vs Host Disease
Start date
2009-01-01
Primary completion
2013-04-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.